Publications by authors named "Sarah Betrian"

Claim this Profile
O
Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapy.
Violeta Romero, Martina Aida Angeles, Elena Rodríguez González, Bastien Cabarrou, Antonio Gil-Moreno

Int J Gynecol Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation of the ENDO-SFOG CAMPUS app: An easy therapeutic decision support app in endometrial cancer created by the French Society of Young Gynecological Oncologists (SFOG Campus).
Virginie Collin-Bund, Floriane Jochum, François Margueritte, Thomas Gaillard, Morgane Perrin, Sarah Betrian

J Gynecol Obstet Hum Reprod· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer.
Mathilde Del, Claire Illac, Mathilde Morisseau, Martina Aida Angeles, Anne Ducassou, Sarah Betrian

Int J Gynecol Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with advanced epithelial ovarian cancer: a European survey.
Floriane Jochum, Martina Aida Angeles, Vincent Balaya, Leonor Drouin, Tanja Nikolova, Sarah Betrian

Arch Gynecol Obstet· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.
Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, Marie Attard, Claire Bournaud, Sarah Betrian

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-fluorouracil with oxaliplatin and/or irinotecan for advanced sinonasal intestinal-type adenocarcinoma (ITAC).
Victor Sarradin, Sarah Betrian, Léonor Chaltiel, Clémence Brac De La Perriere, Jean Pierre Delord

Bull Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study.
Alejandra Martinez, Fabrice Lecuru, Nicolò Bizzarri, Cyrus Chargari, Anne Ducassou, Sarah Betrian

Int J Gynecol Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pattern of recurrence on post-relapse survival according to surgical timing in patients with advanced ovarian cancer.
Martina Aida Angeles, Emanuela Spagnolo, Bastien Cabarrou, Assumpció Pérez-Benavente, Antonio Gil Moreno, Sarah Betrian

Int J Gynecol Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Application in France of the 2021 European recommendations on endometrial cancer].
Elise Deluche, Carolin Marti, Floriane Jochum, Sofiane Bendifallah, Henri Azaïs, Sarah Betrian

Bull Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Endometrial Cancer: French Society of Onco-Gynecology's Evaluation through a Delphi Survey.
Carolin Marti, Elise Deluche, Floriane Jochum, Sofiane Bendifallah, Henri Azais, Sarah Betrian

J Clin Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer.
Sarah Betrian, Martina Aida Angeles, Antonio Gil Moreno, Bastien Cabarrou, Marion Deslandres

Int J Gynecol Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer.
Martina Aida Angeles, Alicia Hernández, Asunción Pérez-Benavente, Bastien Cabarrou, Emanuela Spagnolo

Gynecol Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.
Alejandra Martinez, Elodie Chantalat, Martina Aida Angeles, Gwénaël Ferron, Anne Ducassou

BMC Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basics of immunotherapy for epithelial ovarian cancer.
Virginie Bund, Henri Azaïs, Sabrina Bibi-Triki, Lise Lecointre, Sarah Bétrian Betrian

J Gynecol Obstet Hum Reprod· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer.
Martina Aida Angeles, Bastien Cabarrou, Antonio Gil-Moreno, Asunción Pérez-Benavente, Emanuela Spagnolo

J Gynecol Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of Multiparametric Functional Imaging to Assess Peritoneal Tumor Burden in Ovarian Cancer.
Estelle Mallet, Martina Aida Angeles, Bastien Cabarrou, David Chardin, Philippe Viau, Sarah Betrian

Clin Nucl Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a 2021 French National Survey on Management of Patients with Advanced Stage Epithelial Ovarian Cancer.
Leonor Drouin, Benedetta Guani, Vincent Balaya, Henri Azaïs, Sarah Betrian

J Clin Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Reprint of: SFOG Campus, A new group is born!].
Cherif Akladios, Sofiane Bendifallah, Elise Deluche, Sarah Betrian, Sophie Espenel

Bull Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving patient selection for immuno-oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center.
Ghassan Al Darazi, Elodie Martin, Jean-Pierre Delord, Iphigenia Korakis, Sarah Betrian

Int J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancer.
Martina Aida Angeles, Federico Migliorelli, Mathilde Del, Carlos Martínez-Gómez, Manon Daix

Arch Gynecol Obstet· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of SPECT-CT with intraoperative mapping in cervical and uterine malignancies.
Anne-Sophie Navarro, Martina Aida Angeles, Federico Migliorelli, Claire Illac, Carlos Martínez-Gómez, Sarah Betrian

Int J Gynecol Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SFOG Campus, A new group is born!
Cherif Akladios, Sofiane Bendifallah, Elise Deluche, Sarah Betrian, Sophie Espenel

J Gynecol Obstet Hum Reprod· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending.
Ariadna Ortiz Brugués, Vincent Sibaud, Beatrice Herbault-Barrés, Sarah Betrian, Iphigenie Korakis

Oncologist· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors.
Elena Elez, Carlos Gomez-Roca, Arturo Soto Matos-Pita, Guillem Argiles, Thibaud Valentin, Sarah Betrian

Invest New Drugs· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia.
Sarah Bétrian, Sarah Guenounou, Isabelle Luquet, Cécile Demur, Anne Huynh

Hematol Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis